Avoiding Electromagnetic Interference: FDA Issues Draft Guidance
This article was originally published in The Gray Sheet
The draft lists nine elements, including a summary of testing and results, that FDA wants to see from manufacturers to show new electrical devices pose no electromagnetic interference risk.
You may also be interested in...
In the final medical device electromagnetic compatibility guidance FDA clarified the scope of applications that could use this guidance and added a recommendation for sponsors to identify and consider the intended use environmental that could affect the EMC of their products.
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.